Trial Profile
A randomized controlled study to examine the effects of a triple therapy with vonoprazan or rabeprazole against standard triple therapy-failed patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Aug 2018
Price :
$35
*
At a glance
- Drugs Rabeprazole (Primary) ; Vonoprazan (Primary) ; Amoxicillin; Metronidazole
- Indications Helicobacter pylori infections
- Focus Therapeutic Use
- 06 Aug 2018 Status changed from recruiting to completed.
- 18 Apr 2015 Status changed from not yet recruiting to recruiting as per University Hospital Medical Information Network - Japan.
- 28 Feb 2015 New trial record